VasoRx
Santa Barbara, US · Founded 2018 · Delaware corporation
Founders & leadership
KZ
Krisztina ZseboNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 2 rounds · 2018–2019
▶$3.1MraisedMar 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedMar 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Krisztina ZseboExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.6MraisedApr 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedApr 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Krisztina ZseboExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has VasoRx raised?
- VasoRx has disclosed $4.7M raised across 2 rounds.
- Where is VasoRx headquartered?
- VasoRx is headquartered in Santa Barbara, US.